Apogee Therapeutics, Inc. Common Stock (APGE) Stock Analysis

Apogee Therapeutics, Inc. Common Stock (APGE) is a publicly traded company in the HEALTHCARE sector. It trades at $79.30, carries a market capitalization of $5.98B. This page summarizes the public market data, fundamentals, and frequently asked questions for APGE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $79.30
• Market Cap: $5.98B
• EPS: $-4.33
• 52-Week High: $95.31
• 52-Week Low: $34.34

Market Sentiment

Apogee Therapeutics, Inc. Common Stock currently has a Bullish sentiment score of 0.19.

About Apogee Therapeutics, Inc. Common Stock

Apogee Therapeutics, Inc. is a pioneering biotechnology firm headquartered in Waltham, Massachusetts, dedicated to advancing biologic therapies for chronic inflammatory disorders, such as atopic dermatitis and chronic obstructive pulmonary disease (COPD). With a strong emphasis on innovative science and a promising pipeline, the company aims to fulfill critical unmet medical needs in immunology, thereby enhancing patient outcomes. As Apogee continues to evolve in the biopharmaceutical landsca...

GNG Research Analysis

GNG Research scores Apogee Therapeutics, Inc. Common Stock (APGE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for APGE.

Frequently Asked Questions

Does APGE pay dividends?

Apogee Therapeutics, Inc. Common Stock (APGE) does not currently pay a regular dividend.

What is APGE's market cap?

Apogee Therapeutics, Inc. Common Stock (APGE) has a market capitalization of $5.98B with a current stock price of $79.30.